Peer Review History
Original SubmissionFebruary 10, 2020 |
---|
PONE-D-20-03894 Identifying Healthcare Experiences Associated with Perceptions of Racial/Ethnic Discrimination among Patients with Pain: A Mixed Methods Study PLOS ONE Dear Dr. Hausmann, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by May 31 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, M Barton Laws Academic Editor PLOS ONE Additional Editor Comments (if provided): Please pay particular attention to Reviewer 1's comments about clear explanation of the methodology, and clarity and appropriateness of inference. Journal requirements: When submitting your revision, we need you to address these additional requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. Moreover, please include more details on how the questionnaire was pre-tested, and whether it was validated. 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This manuscript presents findings from a national, cross-sectional survey of VA patients stratified by race/ethnicity (non-Hispanic white vs Hispanic vs black). Authors code open-ended telephone survey responses and then conduct regression analyses to identify correlates of perceived discrimination overall and by veteran race/ethnicity. The focus on veterans with pain is a strength, because racial/ethnic disparities in pain management have been well documented and pain is a common topic of patient dissatisfaction. As detailed below, there are several areas that dampen my enthusiasm: the study design is not clear early on to readers, a clearer focus on implications for pain management (including possibly analyzing pain as a covariate) and more tempered conclusions appropriate to the limitations of cross-sectional data. If these concerns can be addressed, the manuscript has potential to make a meaningful contribution to the literature and advance knowledge. Specific comments: 1. Title. Overall study design and procedures are not clear based on the abstract and intro; I re-read abstract several times and it was not clear until well into methods section that this study is a survey with both closed-ended items and (semi-structured) open-ended interview questions. Emphasizing the “survey” and de-emphasizing the “mixed methods” aspect throughout manuscript will make study design clearer for readers. Specifically, specifying the population and study design in title will decrease potential for reader confusion. Title should be, “Identifying healthcare experiences … among veterans with pain: a cross-sectional mixed methods survey.” 2. Abstract. Edit to make study design clearer for readers. In DESIGN, consider replacing the term “telephone interviews” with “telephone survey.” In MAIN MEASURES, make it clearer that perceived discrimination (dependent variable) and open-ended questions (which were coded and transformed to derive independent variables) were both collected during the same survey interview. I appreciate the mixed methods aspect but the quantitative component is predominant in this study and should drive how study is described. 3. Abstract. Final sentence of CONCLUSION needs to be more qualified / cautious. It is too strong to conclude definitively from this study that findings “underscore the need for interventions…” In addition, implications may be specific to veterans with pain. 4. Introduction, next-to-last paragraph, page 6. Intro discusses the need to understand correlates of perceived discrimination to improve care generally. However, given the known racial/ethnic disparities in pain management, study findings specifically have potential to generate hypotheses/insights that can help to address racial/ethnic disparities in pain management. Making this point explicitly in the intro (and briefly citing literature on racial/ethnic disparities in pain mgmt) would strengthen study justification and make study more compelling for readers. 5. Introduction, final paragraph. Again, study design is difficult to discern from this paragraph. Describing the survey design before the qualitative coding and using the term “mixed methods survey” instead of “mixed methods study” will help clarify design for readers. 6. Participants, page 9. Adding more detail about patient pain would be helpful given the study focus on patients w pain. It is also plausible that pain & pain management would differ for veterans with vs without perceived discrimination. Did parent study collect data on pain (eg pain numeric rating scale, PEG, pain type/location; study mentions that DISC collected administrative VHA data)? If so, pain-specific variables should be included as covariates or at least summarized in Table 2. If parent study did not collect data on patient pain, this should be acknowledged as a limitation. Did the QOL measures include pain-specific items that could be reported separately? 7. Page 10. Specify whether the coders working in teams of two independently applied the master codebook to each interview or whether they coded together as a team. 8. Table 1. This is a nice table. Since “unresolved pain” is a specific code within the quality of care domain, it would be helpful for results to specify proportion of patients for whom this code was present. This might be reported in table 3 or in the manuscript where table 3 is discussed. would also be helpful to note in parentheses after each example the code(s) that example represents within each domain. 9. Table 1. All the examples under “staff demeanor” relate to pain. Since demeanor was one of the significant correlates of perceived discrimination, it would be helpful to describe in results section the prevalence of pain-specific codes for this domain (either quantitatively, qualitatively, or both). A parallel analysis for the other significant domain (interaction w staff) would also be helpful. This additional detail would help convey to readers how salient pain-related comments are among the survey responses, and by extension, the extent to which pain-specific concerns may correlate w perceived discrimination. 10. Pages 20-21. Very interesting that sub-analyses found that “interaction w staff” was correlated w dissatisfaction only for Hispanic vets, while “demeanor” was correlated w dissatisfaction only for black vets. However, on page 20-21 all the examples or “interaction w staff” came from black vets while almost all the examples of “demeanor” came from Hispanic vets. Why is this? 11. Related to point 10 above, I more detailed results about the differences in findings by veteran race/ethnicity would strengthen the study. As mentioned in the intro, discrimination experienced by Hispanic vets is understudied relative to black vets, so including large proportion of Hispanic vets is a particular strength of this study. Although Tables S1 and S3 present some differences by veteran race/ethnicity and there are obvious differences by race/ethnicity, these differences are mostly glossed over in the main manuscript. For Table S3, may be helpful to see differences across all the themes (not just top 3). More nuanced discussion of qualitative and quantitative differences by race/ethnicity (including differences that may not have meet the very strict corrected p value threshold) would help generate hypotheses about how perceived discrimination differs for black vs Hispanic vs NH white veterans, which in turn would increase study impact. 12. Finally, related to point 11 above, manuscript needs to report more detail about perceived discrimination by NH white veterans and the factors/domains correlated with perceived discrimination in these patients compared to Hispanic and black veterans. Introduction (page 6) makes a point to cite prior studies about experience of “reverse discrimination” and states that discrimination can be perceived by vets of any race/ethnicity. However, results and discussion sections only focus on Hispanic and black veterans. 13. Discussion, page 22. Can authors put the prevalence of any perceived discrimination in their sample (37.5%) in context? Is this higher, lower, or similar to rates reported in other studies of veterans or non-veterans? A quick pubmed search found some articles that may be relevant (e.g. Sorkin, D. H., et al. "Racial/ethnic discrimination in health care: Impact on perceived quality of care." Journal of General Internal Medicine 25(5): 390-396). 14. Second sentence of discussion, line 423. “discrimination” should be “perceived discrimination.” 15. Third sentence of discussion, line 428. Both references (ref 8, 24) are specific to patients with sickle cell disease. References more relevant to this study population would be helpful. 16. Discussion, page 22-23. The finding that interpersonal interactions are consistent drivers of perceived discrimination across race/ethnicity is very interesting and important. I appreciate that the “overarching pattern of negative experiences in interpersonal domains … [was similar for] all racial/ethnic groups.” However, more detail about the specific differences and variation across the 3 racial/ethnic groups studied should be included in discussion, even if similarities outweigh differences. As noted above, the intro highlighted the inclusion of Hispanic vets and potential ‘reverse discrimination’ among NH white vets as strengths of this study. Thus, readers will be expecting results and discussions related to these two topics. 17. Discussion, page 23 line 452. Please replace the term “soft skills” with communication skills, remove the scare quotes, and remove communication skills from the list at the start of that sentence. All the examples provided in this paragraph are specific types of communication skills. It is inappropriate to use terminology that implies communication skills are less important or more subjective than other clinical skills. 18. Discussion. On page 25, the authors appropriately discuss limitations of this cross-sectional survey, particularly inability to assess causation or control for unmeasured confounding. However, the paragraph starting on line 443 (pages 23-24) seems to ignore these limitations by suggesting that study results directly support specific future interventions which all implicitly assume that experiencing the themes identified causes perceived discrimination. This paragraph should be much more cautious about results interpretation and next steps and include discussion of both potential ‘causal’ and ‘non-causal’ explanations/interpretations of study findings. Based on data presented, reverse causation is also plausible (i.e. patients who have experienced past discrimination are more likely to report/remember/perceive discrimination in the VA). 19. Page 23, the sentence starting on line 454 (“Disruptive innovations in healthcare models… should also be explored.”) should be deleted. Even setting aside the inability of this study to evaluate causal associations, the data presented does not support or suggest that these types of interventions are likely to reduce perceived discrimination. If anything, the data suggest such “disruptive” system-level innovations would not reduce perceived discrimination, because systems domains (facilities, nonmedical aspects of care, continuity of care, access) were not associated w perceived discrimination in the final model. 20. Similarly, the two sentences starting on page 465 (“not only should such initiatives…in this study”) should be deleted because they do not follow from the data presented and implicitly interpret correlations as causal associations. The study did not address unconscious bias or beliefs about biological difference between races, or how presence of these staff attitudes might relate to the qualitative themes. 21. As noted in prior comments, it would strengthen discussion to talk about whether findings and further efforts to reduce perceived discrimination among veterans has the potential to ameliorate documented racial/ethnic disparities in pain management. 22. Authors have already published data from parent study on positive patient comments (JGIM 2018;33:305-331), where they found no consistent differences in correlates of satisfaction by veteran race/ethnicity. Would be helpful to briefly mention the results of that analysis to put the current findings related to negative comments in context. If correlates of veteran satisfaction are similar across racial/ethnic groups but correlates of dissatisfaction differ by race/ethnicity, that would be a provocative finding, even if it is only preliminary. Reviewer #2: Overall this is a good paper on an important topic. I do have a few thoughts. 1. On page 9 lines 173-174. The authors describe how they excluded participants were missing data on the perceived discrimination measure. However, page 13 second paragraph you wrote that you calculated using values and the perceived discrimination scale by using the mean value of the nine missing items. Which one did you do? 2. On page 18, there is no discussion of pharmacy is the difference between no PD and any PD there was significant at the .001 level 3. on page 22 line 423, the word explain should be changed to identify Which ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
Identifying healthcare experiences associated with perceptions of racial/ethnic discrimination among veterans with pain: A cross-sectional mixed methods survey PONE-D-20-03894R1 Dear Dr. Hausmann, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, M Barton Laws Academic Editor PLOS ONE Additional Editor Comments (optional): Although I am recommending acceptance and do not feel this needs further peer review, please note that both reviewers have made minor queries. You will probably want to address them in the final version of your paper. That said, I am very pleased to see this work be published. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This revised manuscript is substantially improved compared to the initial submission. I appreciate the amount of work the authors put in to this revision. In addition to addressing all my comments, they re-ran analyses using unresolved pain as a separate code. The revised results and revised discussion are now much more interesting. The discussion about differences in experiences associated with perceived discrimination among white, Latino, and black veterans is good, and in particular the finding that unresolved pain was associated with perceived discrimination (particularly among white veterans) was very interesting. The added tables are helpful. This paper represents a useful addition to the literature and should be of interest to PLOS ONE readers. One minor comment - line 124 mentions 9 qualitative domains; the rest of the manuscript mentions 10 domains. please check whether mention of 9 domains on line 124 is a typo. Reviewer #2: I could not find any description of the personnel who conducted the telephone surveys. Are they matched to the ethnicity of the participants? There should be some discussion about this and its potential to bias responses from participants. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No |
Formally Accepted |
PONE-D-20-03894R1 Identifying healthcare experiences associated with perceptions of racial/ethnic discrimination among veterans with pain: A cross-sectional mixed methods survey Dear Dr. Hausmann: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. M Barton Laws Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .